Nesfatin-1 decreased excitability of GI-neurons in DVC. by Jing Dong (102657)

ANG II treatment leads to decreased contractile function. by Renita E. Horton (847891)

“…(E) Representative stress traces generated from x-projections of films (F) ANG II treatment leads to a decrease in contractile stress generation. Control n = 85 tissues, 5 nM n = 15 tissues, 100 nM n = 69 tissues, 3 harvests. …”

Diabetes increases A_2AR density and decreases A₁R density in hippocampal nerve terminals. by João M. N. Duarte (326380)

Acetylation of histone H3 decreases nucleosome stability. by Alexander Gansen (404272)

N2142A mutation could reduce mortality rate and severity of symptoms by decreasing viral loads in limb muscle and spinal cord. by Xue Li (285380)

Subjects:

ATRA improved vimentin organization and decreased its expression. by Carmen Retana (479628)

The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

“…<p><b>A–B:</b> HeLa cells were treated for 3(•) in the presence or absence of 1,000 nM CytoD (□) or 500 nM LatB (▴). …”

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

TMEM16A knockdown induced a decrease in proliferation of SW620 cells. by Yujie Sui (549090)

Spen autonomously decreases fat levels in the fat body. by Kelsey E. Hazegh (4166938)

Rotenone exposure decreases GSH level in porcine oocytes. by Geun Heo (14185618)

Pim overexpression increases and Pim inhibition by DHPCC-9 decreases growth of orthotopic prostate xenografts. by Niina M. Santio (279874)

U-46119 decreases blood flow in the SVZ in vivo. by Benjamin Lacar (332886)

SFN pre-incubation decreases neutrophil respiratory burst. by Irundika H. K. Dias (425605)

Rapamycin decreases phosphorylated mTOR following OGD. by Lauren Fletcher (353321)

“…<p>Primary cortical neurons were subjected to 1 hour OGD and then treated with rapamycin (20 nM) or vehicle (0.01% EtOH) for 24 h. (A) Cells were immunostained with phospho-mTOR Ser-2448 (green), Hoechst (blue) and MAP-2 (red). …”

The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

“…<p><b>A–B:</b> HeLa cells were treated with 1,000(A) or 500 nM LatB (B) for an appropriate length of time. …”

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…The corresponding cross section height measurements show a height decrease by slightly less than 100 nm (from ∼10 nm to −100 nm in the encircled area; lower panel); the arrow in the AFM images points to an intact intercellular connection before cutting (<b>E1</b>) and the disappearance thereof after cutting (<b>E2</b>). …”

Activation of PAR2 decreased the frequency of mEPSCs. by Petra Mrozkova (3226530)

“…Co-application of TRPV1 antagonist SB 366791 (10 μM, 4 min, n = 8) or staurosporine (250 nM, 4 min, n = 10) prevented the inhibitory effect of SLIGKV-NH₂ (100 μM) treatment and the mean mEPSC values were statistically different compared to the application of SLIGKV-NH₂ alone (^#p < 0.05, ^##p < 0.01).…”

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

The MTT assay to determine decreases in residual cell viability in SK-N-BE2 and IMR-32 cells. by Nishant Mohan (474067)

“…As presented in the bar diagrams, combination of 50 nM LC3 shRNA plasmid and 25 µM GST in SK-N-BE2 cells while combination of 100 nM LC3 shRNA plasmid and 25 µM GST in IMR-32 cells showed the best synergistic efficacy, as determined by the combination index (CI) value, for the highest decrease in residual cell viability. …”